Literature DB >> 32420259

Impact of prophylactic unilateral central neck dissection needed for patients with papillary thyroid microcarcinoma.

Young Jae Ryu1, Jung Han Yoon1.   

Abstract

BACKGROUND: Papillary thyroid microcarcinoma (PTMC), the increase in the diagnosis of which has led to an overall rise in the diagnostic rate of thyroid malignancies, is generally managed through a reduction in the surgical extent. Nevertheless, a considerable number of patients with PTMC experience subclinical central lymph node (LN) metastases following prophylactic central neck dissection (CND). This study aimed to investigate the impact of prophylactic CND on locoregional recurrence in PTMC patients who underwent hemithyroidectomy.
METHODS: We reviewed the medical records of 1,071 patients with clinically LN-negative PTMC who underwent hemithyroidectomy between 2004 and 2012. Cox proportional hazards regression analysis was performed to investigate the predictive factors for recurrence. The median follow-up duration was 79 months (range, 12-176 months).
RESULTS: Totally, 613 patients underwent hemithyroidectomy only, whereas 458 underwent hemithyroidectomy plus prophylactic unilateral CND. Recurrence was observed in 27 patients (eight and 19 patients in the prophylactic and non-prophylactic CND groups, respectively). Patients with a tumor size ≤6 mm (hazard ratio, 2.927; 95% confidence interval, 1.372-6.245; P=0.005) had favorable recurrence-free survival (RFS); however, there was no relationship between prophylactic unilateral CND and RFS.
CONCLUSIONS: The incidence of locoregional recurrence was low in patients with PTMC who underwent hemithyroidectomy. In addition, prophylactic unilateral CND performance was not associated with RFS in PTMC. Accordingly, the use of prophylactic unilateral CND for clinically LN-negative PTMC should be avoided. 2020 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Hemithyroidectomy; papillary thyroid carcinoma (PTC); prophylactic central neck dissection (CND); recurrence

Year:  2020        PMID: 32420259      PMCID: PMC7225489          DOI: 10.21037/gs.2020.03.03

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  24 in total

1.  A comparison of lobectomy and total thyroidectomy in patients with papillary thyroid microcarcinoma: a retrospective individual risk factor-matched cohort study.

Authors:  Hyemi Kwon; Min Ji Jeon; Won Gu Kim; Suyeon Park; Mijin Kim; Dong Eun Song; Tae-Yon Sung; Jong Ho Yoon; Suck Joon Hong; Tae Yong Kim; Young Kee Shong; Won Bae Kim
Journal:  Eur J Endocrinol       Date:  2017-01-15       Impact factor: 6.664

2.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

Review 3.  Role of hemithyroidectomy in differentiated thyroid cancer.

Authors:  Bianca Gibelli; Rosa Dionisio; Mohssen Ansarin
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2015-04       Impact factor: 2.064

Review 4.  Management of Papillary Thyroid Microcarcinoma.

Authors:  Juan P Brito; Ian D Hay
Journal:  Endocrinol Metab Clin North Am       Date:  2018-12-23       Impact factor: 4.741

5.  Long-term Results of Observation vs Prophylactic Selective Level VI Neck Dissection for Papillary Thyroid Carcinoma at a Cancer Center.

Authors:  André Ywata de Carvalho; Thiago C Chulam; Luiz P Kowalski
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2015-07       Impact factor: 6.223

6.  Total thyroidectomy versus lobectomy in conventional papillary thyroid microcarcinoma: Analysis of 8,676 patients at a single institution.

Authors:  Seo Ki Kim; Inhye Park; Jung-Woo Woo; Jun Ho Lee; Jun-Ho Choe; Jung-Han Kim; Jee Soo Kim
Journal:  Surgery       Date:  2016-09-01       Impact factor: 3.982

Review 7.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

8.  Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections.

Authors:  Yoon Kyoung So; Young-Ik Son; Sang Duk Hong; Min Young Seo; Chung-Hwan Baek; Han-Sin Jeong; Man Ki Chung
Journal:  Surgery       Date:  2010-03-02       Impact factor: 3.982

9.  Papillary microcarcinoma of the thyroid: predicting factors of lateral neck node metastasis.

Authors:  Jin Young Kwak; Eun-Kyung Kim; Min Jung Kim; Eun Ju Son; Woong Youn Chung; Cheong Soo Park; Kee-Hyun Nam
Journal:  Ann Surg Oncol       Date:  2009-02-18       Impact factor: 5.344

10.  Preoperative ultrasonography and serum thyroid-stimulating hormone on predicting central lymph node metastasis in thyroid nodules as or suspicious for papillary thyroid microcarcinoma.

Authors:  Yi Gao; Ning Qu; Ling Zhang; Jia-Ying Chen; Qing-Hai Ji
Journal:  Tumour Biol       Date:  2015-12-17
View more
  1 in total

1.  Development and validation of an individualized nomogram for predicting the high-volume (> 5) central lymph node metastasis in papillary thyroid microcarcinoma.

Authors:  X Wei; Y Min; Y Feng; D He; X Zeng; Y Huang; S Fan; H Chen; J Chen; K Xiang; H Luo; G Yin; D Hu
Journal:  J Endocrinol Invest       Date:  2021-09-07       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.